Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. Reply.

Saved in:
Bibliographic Details
Title: Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. Reply.
Authors: Hamilton MP; Stanford University School of Medicine, Stanford, CA arasha@stanford.edu., Miklos DB; Stanford University School of Medicine, Stanford, CA arasha@stanford.edu., Alizadeh AA; Stanford University School of Medicine, Stanford, CA arasha@stanford.edu.
Source: The New England journal of medicine [N Engl J Med] 2024 Sep 05; Vol. 391 (9), pp. 870-871.
Publication Type: Letter; Comment
Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1533-4406
DOI:10.1056/NEJMc2408733